Abnormal Lipoprotein and Apolipoprotein Pattern in Lipoprotein Glomerulopathy

Apolipoprotein E polymorphism and atherosclerosis.

Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981 · see citing works

Practical Methods for Plasma Lipoprotein Analysis1 1Work supported in part by the U.S. Atomic Energy Commission and by grants (HE06222 and FR00102) from the U.S. Public Health Service.

Hatch, F. T., & Lees, R. S. (1968) · Advances in lipid research · doi:10.1016/b978-1-4831-9942-9.50008-5 · Cited by 1,235 · see citing works

LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE

Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070 · see citing works

Untitled work

(1985) · PubMed · Cited by 706 · see citing works

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666 · see citing works

Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteins

Utermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337 · see citing works

Type III Hyperlipoproteinemia Associated with Apolipoprotein E Deficiency

Ghiselli, G., Schaefer, E. J., Gascon, P., & Breser, H. B. (1981) · Science · doi:10.1126/science.6795720 · Cited by 274 · see citing works

Pathogenesis, differentiation and management of hypertriglyceridemia.

Havel, R. J. (1969) · PubMed · Cited by 265 · see citing works

A rapid micromethod for apolipoprotein E phenotyping directly in serum

Havekes, L. M., de Knijff, P., Beisiegel†, U., HAVINGA, J. R., de Smit, M. H., & Klasen, E. C. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38697-1 · Cited by 262 · see citing works

The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.

MORGANROTH, J., LEVY, R. I., & FREDRICKSON, D. S. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-2-158 · Cited by 260 · see citing works

Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes

Reaven, G. M., & Greenfield, M. S. (1981) · Diabetes · doi:10.2337/diab.30.2.s66 · Cited by 214 · see citing works

Familial Combined Hyperlipidemia Workshop

Grundy, S. M., Chait, A., & Brunzell, J. D. (1989) · Recent developments in lipid and lipoprotein research · doi:10.1007/978-3-642-83665-7_4 · Cited by 212 · see citing works

Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions

Fredrickson, D. S., MORGANROTH, J., & LEVY, R. I. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-2-150 · Cited by 177 · see citing works

Apolipoprotein E phenotyping from serum by Western blotting

Menzel, H., & Utermann, G. (1986) · Electrophoresis · doi:10.1002/elps.1150071103 · Cited by 174 · see citing works

Lipoprotein Glomerulopathy: Glomerular Lipoprotein Thrombi in a Patient With Hyperlipoproteinemia

Saito, T., Sato, H., Kudo, K.-I., Oikawa, S.-I., Shibata, T., Hara, Y., Yoshinaga, K., & Sakaguchi, H. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80134-9 · Cited by 148 · see citing works

Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.

Rall, S. C., Weisgraber, K. H., Innerarity, T. L., Bersot, T. P., Mahley, R. W., & Blum, C. B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111085 · Cited by 141 · see citing works

Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation

Diamond, J. R., & Karnovsky, M. J. (1987) · Kidney International · doi:10.1038/ki.1987.259 · Cited by 137 · see citing works

Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (Type III hyperlipoproteinemia)

Hazzard, W. R., Porte, D., & Bierman, E. L. (1972) · Metabolism · doi:10.1016/0026-0495(72)90031-5 · Cited by 134 · see citing works

Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome

Gherardi, E., Rota, E., Calandra, S., GENOVA, R., & Tamborino, A. M. (1977) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1977.tb01652.x · Cited by 113 · see citing works

Determination by the SRID Method of Normal Values of Serum Apolipoproteins (A-I, A-II, B, C-II, C-III, and E) in Normolipidemic Healthy Japanese Subjects

Goto, Y., Akanuma, Y., Harano, Y., Yoshiya, H. A. T. A., Itakura, H., Kajiyama, G., KAWADE, M., Shunichi, K. O. G. A., Kuzuya, F., Maruhama, Y., et al. (1986) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.1.73 · Cited by 104 · see citing works

Renal lipidoses: A review

Faraggiana, T., & Churg, J. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80238-1 · Cited by 79 · see citing works

HEPATIC GLOMERULOSCLEROSIS. AN ELECTRON MICROSCOPIC STUDY OF RENAL BIOPSIES IN LIVER DISEASES.

Sakaguchi, H., Dachs, S., Grishman, E., Paronetto, F., Salomon, M., & Churg, J. (1965) · PubMed · Cited by 77 · see citing works

Lipoproteins and Apolipoproteins during the Progression of Chronic Renal Disease

Grützmacher, P., März, W., Peschke, B., Gross, W., & Schoeppe, W. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000185138 · Cited by 75 · see citing works

Aggravation of Broad-ß Disease (Type 3 Hyperlipoproteinemia) by Hypothyroidism

Hazzard, W. R. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.1972.03650060018004 · Cited by 71 · see citing works

A new isoform of apolipoprotein E — Apo E-5 — Associated with hyperlipidemia and atherosclerosis

Yamamura, T., Yamamoto, A., Hiramori, K., & Nambu, S. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90019-4 · Cited by 70 · see citing works

Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations.

Brown, M. S., & Goldstein, J. L. (1975) · PubMed · Cited by 66 · see citing works

A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application

Eto, M., Watanabe, K., & Ishii, K. K. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90269-4 · Cited by 62 · see citing works

A Case of Nephrotic Syndrome with Glomerular Lipoprotein Deposition with Capillary Ballooning and Mesangiolysis

Watanabe, Y., Ozaki, I., Yoshida, F., Fukatsu, A., Itoh, Y., Matsuo, S., & Sakamoto, N. (2008) · Nephron · doi:10.1159/000185297 · Cited by 60 · see citing works

SERUM LIPIDS AND LIPOPROTEINS IN UNTREATED DIABETIC CHILDREN

CHANCE, G. W., Albutt, E. C., & Edkins, S. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91645-6 · Cited by 56 · see citing works

Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia

Kashyap, M. L., Hynd, B. A., Robinson, K., & Gartside, P. S. (1981) · Metabolism · doi:10.1016/0026-0495(81)90158-x · Cited by 49 · see citing works

Familial lecithin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement.

Gjone., E. (1981) · PubMed · Cited by 45 · see citing works

Long-term follow-up of a paediatric case of lipoprotein glomerulopathy

Koitabashi, Y., Ikoma, M., Miyahira, T., Fujita, R., Mio, H., Ishida, M., Shimizu, K., & Sakaguchi, H. (1990) · Pediatric Nephrology · doi:10.1007/bf00858822 · Cited by 26 · see citing works

A Case of Lipoprotein Glomerulopathy: Light and Electron Microscopic Observations of the Glomerulus

Shibata, T., Kaneko, N., Hara, Y., Saito, T., & Sakaguchi, H. (1990) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1990.tb01586.x · Cited by 22 · see citing works

ApoE-2/E-3 ratio of very low density lipoprotein in diabetes mellitus.

SANO, R., Abe, R., Oikawa, S., Fujii, Y., & Toyota, T. (1985) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.146.131 · Cited by 11 · see citing works

Apolipoprotein E phenotypes of normo- and hyperlipoproteinemia in Japanese.

SANO, R., Abe, R., Oikawa, S., FUJII, Y., Hori, S., Suzuki, N., Toyota, T., & Gotō, Y. (1988) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.154.297 · Cited by 10 · see citing works

Lipoprotein Metabolism and Renal Failure

Attman, P., Samuelsson, O. G., & Alaupovic, P. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80030-8 · Cited by 356 · see citing works

Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.

Oikawa, S., Matsunaga, A., Saito, T., Sato, H., Seki, T., Hoshi, K., Hayasaka, K., Kotake, H., Midorikawa, H., Sekikawa, A., et al. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v85820 · Cited by 103 · see citing works

Impact of Lipoprotein Glomerulopathy on the Relationship Between Lipids and Renal Diseases

Saito, T., Matsunaga, A., & Oikawa, S. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.017 · Cited by 96 · see citing works

Apolipoprotein E and renal disease

Liberopoulos, E. N., Siamopoulos, K. C., & Elisaf, M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.013 · Cited by 93 · see citing works

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy

Matsunaga, A., Sasaki, J., Komatsu, T., Kanatsu, K., Tsuji, E., Moriyama, K., Koga, T., Arakawa, K., Oikawa, S., Saito, T., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00572.x · Cited by 91 · see citing works

Preliminary Report on the Association of Apolipoprotein E Polymorphisms, with Postoperative Peak Serum Creatinine Concentrations in Cardiac Surgical Patients

Chew, S. T. H., Newman, M. F., White, W. D., Conlon, P. J., Saunders, A. M., Strittmatter, W. J., Landolfo, K. P., Grocott, H. P., & Stafford‐Smith, M. (2000) · Anesthesiology · doi:10.1097/00000542-200008000-00008 · Cited by 81 · see citing works

Apolipoproteins Prevent Glomerular Albumin Permeability Induced In Vitro by Serum from Patients with Focal Segmental Glomerulosclerosis

Candiano, G., Musante, L., Carraro, M., Faccini, L., Campanacci, L., Zennaro, C., Artero, M. L., Ginevri, F., Perfumo, F., Gusmano, R., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v121143 · Cited by 72 · see citing works

Increased frequency of apolipoprotein ε2 allele in non‐insulin dependent diabetic (NIDDM) patients with nephropathy

Eto, M., Horita, K., Morikawa, A., Nakata, H., Okada, M., Saito, M., Nomura, M., Abiko, A., Iwashima, Y., Ikoda, A., et al. (1995) · Clinical Genetics · doi:10.1111/j.1399-0004.1995.tb04111.x · Cited by 65 · see citing works

Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation

Hu, Z., Huang, S., Wu, Y., Liu, Y., Liu, X., Su, D., Tao, Y., Fu, P., Zhang, X., Peng, Z., et al. (2014) · Kidney International · doi:10.1038/ki.2013.335 · Cited by 60 · see citing works

Virus-mediated Transduction of Apolipoprotein E (ApoE)-Sendai Develops Lipoprotein Glomerulopathy in ApoE-deficient Mice

Ishigaki, Y., Oikawa, S., Suzuki, T., Usui, S., Magoori, K., Kim, D.-H., Suzuki, H., Sasaki, J., Sasano, H., Okazaki, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005906200 · Cited by 58 · see citing works

Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney

MIYATA, T., SUGIYAMA, S., NANGAKU, M., SUZUKI, D., URAGAMI, K.-I., INAGI, R., SAKAI, H., & KUROKAWA, K. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071590 · Cited by 55 · see citing works

Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy

Konishi, K., Saruta, T., Kuramochi, S., Oikawa, S., Saito, T., Han, H., Matsunaga, A., & Sasaki, J. (1999) · Nephron · doi:10.1159/000045513 · Cited by 54 · see citing works

A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy

Ando, M., Sasaki, J., Hua, H., Matsunaga, A., Uchida, K., Jou, K., Oikawa, S., Saito, T., & Nihei, H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00677.x · Cited by 53 · see citing works

Lipoprotein Glomerulopathy: A New Apolipoprotein E Mutation With Enhanced Glomerular Binding

Sam, R., Wu, H., Yue, L., Mazzone, T., Schwartz, M. M., Arruda, J. A. L., Dunea, G., & Singh, A. K. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.031 · Cited by 53 · see citing works

Hyperlipidemia in kidney disease: causes and consequences

Sahadevan, M., & Kasiske, B. L. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200205000-00009 · Cited by 52 · see citing works

Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus

Horita, K., Eto, M., & Makino, I. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90021-3 · Cited by 50 · see citing works

Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants

Saito, T., Oikawa, S., Sato, H., & Sasaki, J. (1999) · Nephron · doi:10.1159/000045511 · Cited by 46 · see citing works

A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy

Ogawa, T., Maruyama, K., Hattori, H., Arai, H., Kondoh, I., Egashira, T., Watanabe, T., Kobayashi, Y., & Morikawa, A. (2000) · Pediatric Nephrology · doi:10.1007/s004670050032 · Cited by 37 · see citing works

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features

Saito, T., Oikawa, S., Sato, H., Sato, T., Ito, S., & Sasaki, J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07110.x · Cited by 37 · see citing works

GENETICS OF LIPOPROTEIN DISORDERS

Davignon, J., & Genest, J. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70024-4 · Cited by 37 · see citing works

Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus

Ha, S.-K., Park, H. S., Kim, K. W., Kim, S. J., Kim, D.-H., Kim, J. H., Lee, H. Y., & Han, D. S. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.9.2144 · Cited by 35 · see citing works

Topics in lipoprotein glomerulopathy: an overview

Saito, T., Matsunaga, A., Ito, K., & Nakashima, H. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0887-4 · Cited by 33 · see citing works

In silico analyses of deleterious missense SNPs of human apolipoprotein E3

Pires, Á. S., Porto, W. F., Franco, O. L., & de Alencar, S. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01737-w · Cited by 29 · see citing works

A Novel Mutation ApoE2 Kurashiki (R158P) in a Patient with Lipoprotein Glomerulopathy

Tokura, T., Itano, S., Kobayashi, S., Kuwabara, A., Fujimoto, S., Horike, H., Satoh, M., Komai, N., Tomita, N., Matsunaga, A., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8102 · Cited by 28 · see citing works

Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury

Saito, T., Satō, H., & Oikawa, S. (1995) · Nephrology · doi:10.1111/j.1440-1797.1995.tb00004.x · Cited by 26 · see citing works

An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy

Li, M.-S., Li, Y., Liu, Y., Zhou, X.-J., & Zhang, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.905007 · Cited by 25 · see citing works

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00148-7 · Cited by 25 · see citing works

A Novel Apolipoprotein E Mutation, ApoE Osaka (Arg158 Pro), in a Dyslipidemic Patient with Lipoprotein Glomerulopathy

Mitani, A., Ishigami, M., Watase, K., Minakata, T., & Yamamura, T. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7377 · Cited by 24 · see citing works

Lipoprotein Glomerulopathy: First Report in a Chinese Male

Zhang, P., Matalon, R., Kaplan, L., Kumar, A., & Gallo, G. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)81066-3 · Cited by 37 · see citing works

The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?

Tramontano, D., D'Erasmo, L., Larouche, M., Brisson, D., Lauzière, A., Di Costanzo, A., Bini, S., Minicocci, I., Covino, S., Baratta, F., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119146 · Cited by 23 · see citing works

Lipoprotein glomerulopathy: a pediatric case report

Maruyama, K., Arai, H., Ogawa, T., Tomizawa, S., & Morikawa, A. (1997) · Pediatric Nephrology · doi:10.1007/s004670050264 · Cited by 23 · see citing works

Apolipoprotein E Polymorphism in IgA Nephropathy

Yorioka, N., Nishida, Y., Oda, H., Watanabe, T., & Yamakido, M. (1999) · The Nephron journals/Nephron journals · doi:10.1159/000045517 · Cited by 22 · see citing works

Abnormal lipid metabolism and renal disorders

Saito, T. (1997) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.181.321 · Cited by 35 · see citing works

The primary glomerulopathies

Glassock, R. J., & Cohen, A. H. (1996) · Disease-a-Month · doi:10.1016/s0011-5029(96)90021-8 · Cited by 20 · see citing works

Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses

Saito, T., Ishigaki, Y., Oikawa, S., & Yamamoto, T. T. (2001) · Clinical and Experimental Nephrology · doi:10.1007/s10157-001-8014-3 · Cited by 18 · see citing works

Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice

Ishimura, A., Watanabe, M., Nakashima, H., Ito, K., Miyake, K., Mochizuki, S., Ishigaki, Y., & Saito, T. (2009) · Clinical and Experimental Nephrology · doi:10.1007/s10157-009-0195-1 · Cited by 17 · see citing works

Association of Apolipoprotein E Polymorphism with Lipoprotein Glomerulopathy

Yang, A. H., Ng, Y. Y., Tarng, D., Chen, J. Y., Shiao, M. S., & Kao, J. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000044933 · Cited by 16 · see citing works

Lipoprotein glomerulopathy

Karet, F. E., & Lifton, R. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v85840 · Cited by 15 · see citing works

Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town

Pasquariello, A., Pasquariello, G., Innocenti, M., Minnei, F., Funel, N., Lorusso, P., & Barsotti, G. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.7772 · Cited by 14 · see citing works

Common Apolipoprotein E Gene Mutations Contribute to Lipoprotein Glomerulopathy in China

Han, J., Pan, Y., Chen, Y., Li, X., Xing, G., Shi, J., Hou, P., Zhang, H., & Wang, H. (2010) · Nephron Clinical Practice · doi:10.1159/000276578 · Cited by 13 · see citing works

Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy

Zhang, B., Liu, Z.-H., Zeng, C.-H., Zheng, J.-M., Chen, H.-P., & Li, L.-S. (2008) · Journal of Nephrology · doi:10.1093/joneph/21.1.110 · Cited by 12 · see citing works

A Common APOE Polymorphism Is an Independent Risk Factor for Reduced Glomerular Filtration Rate in the Spanish RENASTUR Cohort

Coto, E., Gómez, J., Tavira, B., Tranche, S., Ortega, F. B., Rodríguez, M. I., Sánchez, E., Marín, R., Corao, A. I., Arenas, J., et al. (2013) · Cardiorenal Medicine · doi:10.1159/000351158 · Cited by 12 · see citing works

Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy

Miyahara, Y., Nishimura, S., Watanabe, M., Ito, K., Nakashima, H., & Saito, T. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0554-6 · Cited by 12 · see citing works

Two-dimensional analysis of tear protein patterns of diabetic patients

Herber, S., Grus, F. H., Sabuncuo, P., & Augustin, A. J. (2001) · Electrophoresis · doi:10.1002/1522-2683(200105)22:9 · Cited by 102 · see citing works

Lipoprotein Glomerulopathy and Its Pathogenesis

Saito, T., Oikawa, S., Sato, H., & Chiba, J. (1997) · Contributions to Nephrology · doi:10.1159/000059821 · Cited by 12 · see citing works

Significance of a Novel Apolipoprotein E Variant, ApoE Osaka/Kurashiki, in Lipoprotein Glomerulopathy

Saito, T., & Matsunaga, A. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10165 · Cited by 7 · see citing works

A newborn infant with lipoprotein glomerulopathy associated with congenital nephrotic syndrome

Shimizu, M., Ohno, T., Kimoto, H., Hosono, S., & Nozawa, M. (2001) · Pediatrics International · doi:10.1046/j.1442-200x.2001.01344.x · Cited by 8 · see citing works

Lipoprotein Glomerulopathy in a Hispanic Female: A Case Report and Literature Review

Majeed, N. K., McLaughlin, J., & Gonzalez, M. (2019) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358119859576 · Cited by 6 · see citing works

Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report

Li, Y., Chen, J., Zou, Y., Wang, W., & Li, G. (2022) · Medicine · doi:10.1097/md.0000000000028718 · Cited by 5 · see citing works

Intravascular cardiac lipoproteinosis: extrarenal manifestation of lipoprotein glomerulopathy

Morris, C. S., Bois, M. C., Aust, C. H., Thomas, R., Sethi, S. M., & Maleszewski, J. J. (2019) · Cardiovascular Pathology · doi:10.1016/j.carpath.2019.04.006 · Cited by 4 · see citing works

Lipoprotein Glomerulopathy With Complete Resolution With Fenofibrate: Report of First Case From Pakistan

Shaker, N., Musa, R. B., Shaker, N., Nasir, H., Kamran, T. E., Poombal, F., Abid, A., Shakra, R. I. A., & Mansoor, I. (2024) · International Journal of Surgical Pathology · doi:10.1177/10668969241228298 · Cited by 3 · see citing works

Patient with lipoprotein glomerulopathy complicated with central retinal artery obstruction.

武生, 小., 佳典, 藤., 弘之郎, 槇., & 金津, 和. (1995) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.84.1332 · Cited by 1 · see citing works

内科 １００年のあゆみ 腎臓 ＩＩ 日本人の貢献 ７ Ｌｉｐｏｐｒｏｔｅｉｎ ｇｌｏｍｅｒｕｌｏｐａｔｈｙ

喬雄, 斉. (2002) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.91.1444 · Cited by 1 · see citing works

Microalbuminuria in Essential Hypertension. Significance for the Cardiovascular and Renal Systems

Campese, V. M., Bigazzi, R., & Bianchi, S. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4499-9_43

Diabetic nephropathy—an acquired or inherited disease?

Groop, P., & Forsblom, C. M. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00135-3

A new variant of apolipoprotein E in a girl with lipoprotein glomerulopathy.

Ogawa, T., Arai, H., Watanabe, T., Kobayashi, Y., Morikawa, A., Maruyama, K., Hattori, H., & Egashira, T. (1998) · Japanese journal of pediatric nephrology · doi:10.3165/jjpn.11.171

Disease state of lipoprotein glomerulopathy.

斉藤, 喬. (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.1838

Apo E Variant (Apo E Sendai) and Lipoprotein Glomerulopathy

OIKAWA, S.-I., Hoshi, K., Hayasaka, K., MIDORIKAWA, H., Sekikawa, A., Toyota, T., Saito, T., Matsunaga, A., & SASAKI, J. (1997) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.24.10_523

Docking and Molecular Interaction of Apolipoprotein E with Plasma Lipoproteins

Monteiro, V. K. F., Rodrigues, M. V. F., de Alencar, S. A., & Monteiro, N. D. K. V. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_3-1

Docking and Molecular Interaction of Apolipoprotein E with Plasma Lipoproteins

Monteiro, V. K. F., Rodrigues, M. V. F., de Alencar, S. A., & Monteiro, N. D. K. V. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_3

Lipoprotein Glomerulopathy

Saito, T., Sato, H., Oikawa, S., Kudo, K., Kurihara, I., Nakayama, K., Abe, K., Yoshinaga, K., & Sakaguchi, H. (1993) · American Journal of Nephrology · doi:10.1159/000168591 · Cited by 57 · see citing works

Lipoprotein Glomerulopathy: First Report in a Chinese Male

Zhang, P., Matalon, R., Kaplan, L., Kumar, A., & Gallo, G. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)81066-3 · Cited by 37 · see citing works

Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury

Saito, T., Satō, H., & Oikawa, S. (1995) · Nephrology · doi:10.1111/j.1440-1797.1995.tb00004.x · Cited by 26 · see citing works

Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town

Pasquariello, A., Pasquariello, G., Innocenti, M., Minnei, F., Funel, N., Lorusso, P., & Barsotti, G. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.7772 · Cited by 14 · see citing works

Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity

Karube, M., Nakabayashi, K., Fujioka, Y., Yoshihara, K., Yamada, A., Matsunaga, A., & Saito, T. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0469-4 · Cited by 6 · see citing works